Institut für Medizinische Biometrie
und Statistik (IMBI)

Prof. Dr. Anne-Laure Boulesteix

IBE Ludwigs-Maximilians-University München

On random forests, omics data and benchmark studies

Jon Michael Gran

Associate Professor at the Institute of Basic Medical Sciences, University of Oslo

Estimating causal effects in non-Markov multi-state models

Dr. Katharina Schultebraucks

NYU School of Medicine, Department of Psychiatry

Identifying early risk factors for PTSD - a machine learning approach

Dr. James A. Hanley

McGill University Montreal

Match or model? sample or entire base? Statistical strategies in etio‐, dia‐, and pro‐gnostic research

Mark Baillie

Novartis, Basel

How do we make better graphs? Effective visual communication for the quantitative scientist

Prof. Dr. Riccardo De Bin

University of Oslo, Department of Mathematics

Detection of influential points as a byproduct of resampling‐based variable selection procedures

Dr. Tibor Schuster

Mc Gill.CA, Department of Family Medicine

Non-collapsibility: the root of all evil when estimating and interpreting marginal hazard ratios.

Georg Heinze

Medical University of Vienna

Prediction and explanation in studies with rare events: problems and solutions.

Georg Heinze, Christine Wallisch

Medical University of Vienna, Center for Medical Statistics, Informatics and Intelligent Systems

Variable selection – a review and recommendations for the practicing statistician.

Prof. Micha Mandel

Department of Statistics, The Hebrew University of Jerusalem

The illness–death model under cross-sectional sampling.

Vivian Viallon

Nutritional Methodology and Biostatistics Group (NMB) International Agency for Research on Cancer World Health Organization

Using structural causal models to identify biases in standard epidemiological analyses.

Prof. Dr. Reinhard Meister

Beuth Hochschule für Technik Berlin

Prof. Dr. Heiko Becher

Universitätsklinikum Hamburg-Eppendorf

Methods to estimate the number of lung cancer cases caused by passive smoking in Germany

Prof. Dr. Martin Schumacher
11 Dinge, die man bei der Analyse biomedizinischer Daten unbedingt vermeiden sollte

Prof. Dr. Harald Binder
Künstliche Intelligenz, Deep Learning und die Rolle der Biometrie

Itai Dattner

Department of Statistics, University of Haifa, Israel

Statistical learning of age-dependent dynamics from incidence data

Walter Zingg

University of Geneva

Assessing the burden of healthcare-associated infection by prevalence surveys

Dr. Alison Abraham, PhD

The Johns Hopkins University School of Medicine

Clinical care practice and the cohort study: moving from observation to intervention

Dr. Ewelina Kotwa

On robust statistics, chemometrics and the importance to know what we are doing!

Dr. Steffen Unkel

Institut für Med. Statistik, Universitätsmedizin Göttingen

Statistical Methods for Outbreak Detection

Dr. Benjamin Blümel

Institut für Mikrobiologie und Hygiene, Universitätsklinikum Freiburg

Microbiological Hospital Data from the Medical Center Freiburg

Prof. Dr. André Scherag

Universitätsklinikum Jena

Methodological challenges of hospital-wide nosocomial infection monitoring within the ALERTS study - an example of our ongoing work within the "Center for Sepsis Control and Care" (CSCC)

Yessica Fermin

Abt. Statistik, Uni Dortmund

Nonparametric Bayesian analysis of dynamic protein-networks in heterogeneous cell populations

Prof. Dr. Meinhard Kieser

Medizinische Biometrie und Informatik, Universitätsklinikum Heidelberg

Phase-II-Studien in der Onkologie – Ist Simons optimales Design das Optimum?

Univ.‐Prof. Dr. med. Rafael Mikolajczyk

Helmholtz Zentrum für Infektionsforschung, Braunschweig

Insights from network modelling of the spread of pathogens between hospitals

Workshop: Pseudovalues und Supermodels

Alina Nicolaie (RIVM, Netherlands)
Dynamic pseudo-observations: A robust approach to dynamic prediction in competing risks

Daniela Zöller (Uni Mainz)
Using pseudo-values and simultaneous variable selection to extract a core set of variables for dynamic prediction models

Maja von Cube (Uni Freiburg)
Dynamic prediction approach to analyse the population-attributable fraction of hospital-acquired infections

Harriet Sommer (Uni Freiburg)
The cure-death model and its application to observational studies

Alex Aiken

Matched parallel cohort study designs to evaluate the burden of nosocomial infections

Prof. Dr. Casey Rebholz

Johns Hopkins University Baltimore

Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease in the Atherosclerosis Risk in Communities (ARIC) Study: An Application of Structural Equation Modeling

Dr. Christine Gräfin zu Eulenburg, Karl Wegscheider

Universität Hamburg

Selection bias in on-treatment analyses: results from the Serve-HF study

Madlen Gebauer and Jan Beyersmann

Institute of Statistics, Ulm University

Nested case-control designs in a subsequent event setting

Dr. Riccardo De Bin

Medizinische Informationsverarbeitung, Biometrie und Epidemiologie - Schwerpunkt Biometrie, Ludwig-Maximilians-Universität München

On the use of different strategies to combine clinical and high-throughput omics predictors in a prediction model

Prof. Dr. Tim Friede

Department of Medical Statistics, University Medical Center Göttingen

Exploratory and confirmatory subgroup analyses in clinical trials

Prof. Dr. Markus Scholz

Institut für Medizinische Informatik, Statistik und Epidemiologie, Universität Leipzig

On the molecular-genetic research program of the LIFE study

Bella Vakulenko-Lagun

Department of Statistics, The Hebrew University of Jerusalem

What could be done with prevalent data in the illness-death model?

Guiliana Cortese

Department of Statistical Sciences, Padua University

Prediction Models for Competing Risks with time-dependent covariates

Christian Hennig

University College London

Measurement of quality in cluster analysis

Dr. Aris Perperoglou

Essex

Approaches in modelling long term survival: models, time functions and some data

Nathalie Stoer

Reuse of controls from nested case-control designs

Prof. Dr. med. Antje Timmer

Fakultät VI, Department für Versorgungsforschung, Carl von Ossietzky Universität Oldenburg

„Alte Schläuche, neue Kühe“ - Versorgungsforschung und klinische Epidemiologie.

Ralf Bender, Stefan Lange

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)

Analyse unerwünschter Ereignisse im Rahmen der Nutzenbewertung von Arzneimitteln.

Simon Wood

Mathematical Science, University of Bath, UK

Additive models beyond exponential family: smooth Cox proportional hazards etc.

Prof. Dr. Rolf Holle

Helmholtz Zentrum München

Besonderheiten ökonomischer RCTs am Beispiel der KORINNA-Studie

Dr. Isabella Zwiener

Universität Mainz

Building prognostic gene signatures with RNA-Seq data

Virginie Rondeau

Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units

Philipp Doebler

WWU Münster

Diagnostic meta‐analysis with the R‐package mada

Ulrike Krahn

Evaluating the validity of network meta-analyses: locating inconsistency and visualizing the flow of evidence

Prof. Dr. Joachim Röhmel

Systematische Übersichtsarbeiten zur „ethischen“ Literatur. Konzeptionelle und praktische Herausforderungen

Prof. Dr. Werner Vach

Über die Sinnhaftigkeit der gesetztlichen Vorgaben zur Quantifizierung und Kategorisierung des Zusatznutzens bei Arzneimitteln

Daniel Strech

Systematische Übersichtsarbeiten zur „ethischen“ Literatur. Konzeptionelle und praktische Herausforderungen

Prof. Hans van Houwelingen

Leiden University Medical Center

Dynamic prediction of survival with clinical and genomic data

Anna Nachtnebel

Ludwig Boltzmann Institut für Health Technology Assessment

Evaluation von Diagnostika aus der HTA- Perspektive

Laura Antolini

Performance of binary markers for censored failure time outcome: nonparametric approach based on proportions

Prof. Dr. Ulrich Mansmann

Counter-factual responder analysis in parallel group RCTs using covariates

Nicholas Graves

Economics and cost-effectiveness modelling for reducing healthcare acquired infection

Georg Heinze

Section for Clinical Biometrics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria

Nonlinear interactions, confounding, and missing values: an interesting case study

Dr. Heike Spaderna

Spielen psychosoziale und verhaltensbezogene Patientenmerkmale eine Rolle für die Prognose während der Wartezeit auf eine Herztransplantation? – Anwendung eines competing risks-Modell.

Dr. Oliver Teuffel

The Hospital for Sick Children, Toronto, Canada

Ambulante Therapiestrategien zur Behandlung von Fieber und Neutropenie: Eine Kosten-Nutzwert Analyse.

Bernd Fitzenberger

MCMC estimation of the heterogeneous effects of treatment incidence and treatment duration.

Raymond J. Carroll

Robust Powerful Methods for Understanding Gene-Gene and Gene-Environment Interactions

Cornelis Biesheuvel, Stockholm

Overdiagnosis of invasive breast cancer associated with mammograhpy screening

Holger Höfling

Estimation of Sparse Binary Markov Networks

Prof. Hans C. van Houwelingen, Leiden University Medical Center

Frailties in multi-state models: Are they identifiable? Do we need them?

Adrian Barnett

Estimating the effect of Methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit using a longitudinal model

Mei-Jie Zhang

Modeling Right Censored and Left Truncated Competing Risks Failure Time Data Using Inverse Weighting Technique

Jean-Francois Timsit

Estimation of the Excess mortality of nosocomial infections and iatrogenic events: Potential Pitfalls

Theo Stijnen

Meta-analysis of diagnostic test accuracy data

Ananthram Murthy

Principles of health economic evaluation: Cost-effectiveness of universal rapid screening of MRSA.

Dr. Oliver Kuss

Institut für Medizinische Epidemiologie, Biometrie und Informatik, Martin-Luther-Universität Halle-Wittenberg

Gibt es einen Unterschied zwischen randomisierten und nicht-randomisierten Studien in ähnlichen Patientegruppen? - Evidenz aus einer „Meta-Propensity Score-Analyse“ in der Herzchirurgie

Raphael Porcher

Département de Biostatistique et Informatique Médicale, Hôpital Saint Louis Paris

Adaptive and flexible designs

David Siegmund

Stanford University

Mapping Quantitative Traits

Prof. Reinhard Meister

Berlin

The competing risk approach adapted to left truncation allows reliable estimation of abortion risk from observational studies.

Antje Jahn-Eimermacher

Statistical analysis of recurrent failure time data: Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children.

Stijn Vansteelandt

Department of Applied Mathematics and Computer Science, Ghent University, Belgien

Marginal Structural Models for the effect of ICU-acquired nosocomial pneumonia on survival.

Anne-Laure Boulesteix

Sylvia Lawry Centre for Multiple Sclerosis Research, München

Hybrid classifiers based on clinical predictors and high-dimensional microarray data using PLS and random forests

Laurence Colin

Novartis Basel

A Multivariate Survival Analysis of Recurrent Surgical Interventions for Retinal Detachment: the SPR Study

Melanie Weck

Heidelberg

Association of Helicobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition

Marta Fiocco

Leiden University, Netherlands

A multi-state model for bone marrow transplantation using the mstate package

Marcel Wolber

Basel Institute for Clinical Epidemiology, University Hospital Basel, Switzerland

Two-stage Randomization Designs in Drug Development

Stéphane Hugonnet

University of Geneva Hospitals, Switzerland, Infection control program

Nosocomial infection: a look into risk factors and methodological issues

Dr. Laura Antolini

Universita of Milano-Bicocca, Dipartimento di medicina clinica prevenzione e biotecnologie sanitarie

Explained Variation and Discrimination Measures for Censored Survival Data

Dr. Martin Bootsma

Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London

Estimating transmission parameters for infectious diseases in small hospital units

Dr. Donna Pauler Ankerst

Research Scientist Institute for Medical Informatics, Biometry and Epidemiology; University of Munich

Joint statistical models for longitudinal prostate-specific antigen (PSA) and time of prostate recurrence: do they improve prediction of recurrence for new patients?

Dr. Guido Knapp

Fachbereich Statistik, Universität Dortmund

Neuere statistische Methoden in der Meta-Analyse

Prof. Per Kragh Andersen

Regression analysis for multistate models based on a pseudo-value approach, with applications to bone marrow transplantation studies.

Dr. Christine Lonjou

INSERM Toulouse

Disease mapping and linkage disequilibrium based approach

Aurelien Latouche

Regression Modelling of Competing Risks

Dr. James Carpenter

Values in Clinical Trials: Handle with Sensitivity!

Prof. Dr. Dieter Hölzel

Bevölkerungsbezogene Krebsregister: eine Infrastruktur für die Versorgung und die klinische Forschung mit Analysen zur Metastasierung beim Mammakarzino

Dr. Til Stürmer

Controlling Confounding Using Propensity Scores: Increasing Use, Persisting Questions, and New Venues

Professor Gerda Claeskens

Frequentist model averaging and focussed model selection

Elke Klein

Validierung von SAS-Programmen zur Auswertung klinischer Studien

Hein Putter

Reduced rank proportional hazards models for competing risks

PD Dr. Tom Smith

Assessment of positivity in immuno-assays with variability in background measurements: a new approach applied to the antibody response to Plasmodium falciparum MSP2

Dr. Ulrich Schach

Modellierung von MRI-Parametern in der Krankheitsanalyse von Multipler Skleros